Abstract

PurposeSurgical treatment options for the management of focal chondral and osteochondral lesions in the knee include biological solutions and focal metal implants. A treatment gap exists for patients with lesions not suitable for arthroplasty or biologic repair or who have failed prior cartilage repair surgery. This study reports on the early clinical and functional outcomes in patients undergoing treatment with an individualised mini-metal implant for an isolated focal chondral defect in the knee.MethodsOpen-label, multicentre, non-randomised, non-comparative retrospective observational analysis of prospectively collected clinical data in a consecutive series of 80 patients undergoing knee reconstruction with the Episealer® implant. Knee injury and Osteoarthritis Outcome Score (KOOS) and VAS scores, were recorded preoperatively and at 3 months, 1 year, and 2 years postoperatively.ResultsSeventy-five patients were evaluated at a minimum 24 months following implantation. Two patients had undergone revision (2.5%), 1 declined participation, and 2 had not completed the full data requirements, leaving 75 of the 80 with complete data for analysis. All 5 KOOS domain mean scores were significantly improved at 1 and 2 years (p < 0.001–0.002). Mean preoperative aggregated KOOS4 of 35 (95% CI 33.5–37.5) improved to 57 (95% CI 54.5–60.2) and 59 (95% CI 55.7–61.6) at 12 and 24 months respectively (p < 0.05). Mean VAS score improved from 63 (95% CI 56.0–68.1) preoperatively to 32 (95% CI 24.4–38.3) at 24 months. The improvement exceeded the minimal clinically important difference (MCID) and this improvement was maintained over time. Location of defect and history of previous cartilage repair did not significantly affect the outcome (p > 0.05).ConclusionThe study suggests that at 2 years, Episealer® implants are safe with a low failure rate of 2.5% and result in clinically significant improvement. Individualised mini-metal implants with appropriate accurate guides for implantation appear to have a place in the management of focal femoral chondral and osteochondral defects in the knee.Level of evidenceIV.

Highlights

  • Focal chondral and osteochondral lesions are a significant cause of morbidity and can have a clinical impact similar to end-stage osteoarthritis, with an important socio–economic burden [15, 17]

  • Treatment was indicated for patients with symptomatic chondral and osteochondral defects in the knee who had failed conservative treatment and who were suitable for the procedure as determined on specific Magnetic Resonance Imaging (MRI) imaging and satisfactory mapping according to an individualised damage marking report

  • Articular surface reconstruction using an individualised mini-metal implant designed according to detailed MRI imaging, in combination with specific insertion guides, resulted in significant clinical and functional improvement at 2 years

Read more

Summary

Introduction

Focal chondral and osteochondral lesions are a significant cause of morbidity and can have a clinical impact similar to end-stage osteoarthritis, with an important socio–economic burden [15, 17]. Lesions are likely to progress to bifocal disease and pan-articular osteoarthritis [4, 7, 29].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call